Log in to save to my catalogue

Multidrug-Resistant ESBL-Producing E. coli in Clinical Samples from the UK

Multidrug-Resistant ESBL-Producing E. coli in Clinical Samples from the UK

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9cc51c723dcf456486d0cd90617a2ee8

Multidrug-Resistant ESBL-Producing E. coli in Clinical Samples from the UK

About this item

Full title

Multidrug-Resistant ESBL-Producing E. coli in Clinical Samples from the UK

Publisher

Switzerland: MDPI AG

Journal title

Antibiotics (Basel), 2023-01, Vol.12 (1), p.169

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Globally, cephalosporin therapy failure is a serious problem for infection control. One causative agent of cephalosporin-resistant infections is multidrug-resistant (MDR) E. coli producing extended-spectrum β-lactamases (ESBLs) and/or plasmid-encoded AmpC (pAmpC) β-lactamases. We evaluated the occurrence of ESBL/pAmpC genetic determinants in phenot...

Alternative Titles

Full title

Multidrug-Resistant ESBL-Producing E. coli in Clinical Samples from the UK

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9cc51c723dcf456486d0cd90617a2ee8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9cc51c723dcf456486d0cd90617a2ee8

Other Identifiers

ISSN

2079-6382

E-ISSN

2079-6382

DOI

10.3390/antibiotics12010169

How to access this item